CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy
- 15 December 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (6) , 1261-1272
Abstract
Key Points: CFHR3*B haplotype was a susceptibility variant for IgA nephropathy diagnosis by enhancing complement activation. The rs446868A variant in CFHR3*B elevated CFHR3 transcription and was associated with higher circulating FHR3 levels in patients with IgA nephropathy. FHR3241Ser variant enhanced C3b binding and complement activation, accelerating IgA deposition–induced complement activation in IgA nephropathy. Background: Complement activation is involved in IgA nephropathy. We previously identified that genetic deletion of CFHR3 and CFHR1 confers protection against IgA nephropathy by modulating complement activation. In addition, the CFHR3*B haplotype (rs385390C/rs446868A/rs138675433T/rs149352569T) has been linked to elevated CFHR3 transcription and higher risk of atypical hemolytic uremic syndrome. Methods: We evaluated the association between the CFHR3*B haplotype and IgA nephropathy susceptibility by using genetic analysis of 1108 patients with IgA nephropathy and 630 healthy controls. Luciferase activity assays were performed to assess the transcriptional activity of CFHR3*B haplotype. The coding variant rs138675433 (FHR3 241Pro versus FHR3 241Ser ) was assessed using recombinant proteins to determine its effect on complement regulation. Results: The CFHR3*B haplotype and CFHR3*BB genotype were significantly enriched in patients with IgA nephropathy. The CFHR3*BB genotype correlated with lower circulating C3 levels and greater glomerular C3 deposition. Luciferase activity assays demonstrated enhanced transcription activity conferred by the CFHR3*B haplotype, with rs446868 identified as the functional regulatory variant. Patients carrying the CFHR3*BB genotype exhibited elevated circulating FHR3 levels. FHR3 241Ser exhibited significantly enhanced C3b-binding capacity and factor H deregulation activity, promoting accelerated C3 convertase formation and increased hemolysis. Furthermore, FHR3 241Ser augmented IgA deposition–induced complement activation on cultured mesangial cells in a dose-dependent manner. Conclusions: Our results identified CFHR3*B haplotype as a susceptibility variant for IgA nephropathy diagnosis by accelerating complement activation, through rs446868A enhancing transcription activity and rs138675433T augmenting FHR3 function.Keywords
Funding Information
- National Natural Science Foundation of China (82270740)
- National Natural Science Foundation of China (8247034)
- National Natural Science Foundation of China (82170710)
- National Natural Science Foundation of China (22321005)
- Beijing New-star Plan of Science and Technology (20230484486)
- National Key Research and Development Program of China (2024YFC2511000)
This publication has 40 references indexed in Scilit:
- Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrationsThe American Journal of Human Genetics, 2022
- Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein concentrationsThe American Journal of Human Genetics, 2021
- The role of complement in IgA nephropathyMolecular Immunology, 2019
- Circulating complement factor H–related protein 5 levels contribute to development and progression of IgA nephropathyKidney International, 2018
- Role of complement in IgA nephropathyJournal Of Nephrology, 2015
- Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndromeMolecular Immunology, 2015
- C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA NephropathyJournal of Clinical Immunology, 2013
- Natural history of idiopathic IgA nephropathy and factors predictive of disease outcomeSeminars in Nephrology, 2004
- Functional properties of complement factor H‐related proteins FHR‐3 and FHR‐4: binding to the C3d region of C3b and differential regulation by heparinFEBS Letters, 1999
- Factor H and disease: a complement regulator affects vital body functionsMolecular Immunology, 1999